Page 9 - Special Access Program News Today

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and effica...

/PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin treatments is...

Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada. 

Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose drug protocol to patient Kelsi Sheren, a…

Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada. 

Filament Health Corp (OTCQB:FLHLF)s diversified business model makes it one of the only psychedelics companies to be already generating revenue.   The...

Canadian not-for-profit organization TheraPsil has received board approval to launch its training program on MDMA-assisted psychotherapy for trauma survivors.

“People are going to have their medically-assisted death covered [by government funding], but they won’t have their psilocybin therapy covered.”

Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.) 

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) is celebrating the successful implantation of its new class of biomimetic valves, the world’s only...